MA49488A - ANTIBODY VARIANTS - Google Patents

ANTIBODY VARIANTS

Info

Publication number
MA49488A
MA49488A MA049488A MA49488A MA49488A MA 49488 A MA49488 A MA 49488A MA 049488 A MA049488 A MA 049488A MA 49488 A MA49488 A MA 49488A MA 49488 A MA49488 A MA 49488A
Authority
MA
Morocco
Prior art keywords
antibody variants
variants
antibody
Prior art date
Application number
MA049488A
Other languages
French (fr)
Inventor
Esther Furrer
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Priority to MA049488A priority Critical patent/MA49488A/en
Publication of MA49488A publication Critical patent/MA49488A/en

Links

MA049488A 2017-09-19 2017-09-19 ANTIBODY VARIANTS MA49488A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA049488A MA49488A (en) 2017-09-19 2017-09-19 ANTIBODY VARIANTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA049488A MA49488A (en) 2017-09-19 2017-09-19 ANTIBODY VARIANTS

Publications (1)

Publication Number Publication Date
MA49488A true MA49488A (en) 2020-05-06

Family

ID=77631567

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049488A MA49488A (en) 2017-09-19 2017-09-19 ANTIBODY VARIANTS

Country Status (1)

Country Link
MA (1) MA49488A (en)

Similar Documents

Publication Publication Date Title
MA47694A (en) ANTI-TIGIT ANTIBODY
MA49034A (en) ANTI-LAG3 ANTIBODY
MA49043A (en) STABLE ANTIBODY FORMULATION
MA53434A (en) ANTI-TIGIT ANTIBODIES
MA47268A (en) ANTIBODY ANTI-GPC3
MA52884A (en) ANTI-IL-11 ANTIBODIES
MA46525A (en) ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS
MA50505A (en) 2 + 1 BISPECIFIC ANTIBODIES (CONTORSBODIES)
MA44659A (en) ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS
MA46041A (en) ANTI-BODY ANTI-TIM -3
MA56006A (en) SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
MA42924A (en) OPTIMIZED VARIANTS OF ANTI-VEGF ANTIBODIES
MA44381A (en) MULTISPECIFIC HETERODIMERIC ANTIBODY FORMAT
MA52212A (en) MULTIVALENT ANTIBODY
MA49749A (en) ANTI-CD137 ANTIBODY
MA49726A (en) FORMULATION OF ANTI-CGRP ANTIBODIES
MA45231A (en) ANTI-BODY ANTI-IGE
MA44236A (en) ANTI-TGFBETA ANTIBODY 2
MA52152A (en) ANTIBODY
MA44054A (en) BISPECIFIC ANTIBODY PLATFORM
MA52366A (en) OPTIMIZED ANTI-TL1A ANTIBODIES
MA51134A (en) ANTI-ALPHA-SYNUCLEIN ANTIBODY
MA42843A (en) ANTI-CD115 ANTIBODY
MA54052A (en) ANTIBODY FORMULATION
MA54139A (en) ANTIBODY FORMULATION